Safety and Preliminary Efficacy of Intranasal Insulin for Cognitive Impairment in Parkinson Disease and Multiple System Atrophy 1.0
(1,078 bytes)
variable | variable_description | units | example_1 | example_2 |
Study Number | The subject identifier | 4 | 5 | |
IversusP | Insulin vs Placebo | 0=Placebo, 1=Insulin | 0 | 1 |
Age | Age | Years | 53 | 71 |
Gender | Gender | 1=Man. 2=Woman | 2 | 1 |
Etnicity | Etnicity | White | African American | |
Smoking | Smoking (Yes/No) | 0=No, 1=Yes | 0 | 0 |
Height (in) | Height | Inches | 67 | 68 |
Weight | Weight | Pounds | 155 | 157 |
BMI | Body Mass Index | kg/m2 | 24.3 | 23.9 |
Disease | PD=Parkinson Disease | PD | PD | |
Disease Duration | Disease Duration | Years | 5 | 17 |
SBP | Systolic Blood Pressure | mmHg | 113 | 114 |
DBP | Diastolic Blood Pressure | mmHg | 69 | 74 |
HR | Heart rate | beats/min | 70 | 62 |
Walk-Duration | Walk Duration | seconds | 3.84 | 3.37 |
Walk-NoSteps | Number of steps | # | 8 | 7 |
AverStride (in) | Average Stride Length (Walk distance/Number of steps) | Inches | 18 | 21 |
MOCA | The Montreal Cognitive Assessment | 28 | 26 | |
Glucose | Serum glucose | mg/dL | 98 | 83 |
Gait Speed | Gait speed | m/s | 1.136363636 | 1.567398119 |
BDI | The Beck Depression Inventory | 15 | 6 | |
F#words | Words starting with letter F | # | 11 | 16 |
A#words | Words starting with letter A | # | 11 | 12 |
S#words | Words starting with letter S | # | 12 | 9 |
FAS | Verbal Fluncy Test | 34 | 37 |